Prospects of anti-B-cell therapy for systemic sclerosis
Systemic sclerosis (SSc) is a severe systemic autoimmune rheumatic disease (SARD), pathogenetically associated with inflammation and pathological disorders in the microvascular bed, leading to the development of autoimmune fibrosis and vasculopathy. An important role in the pathogenesis of SSc is pl...
Saved in:
| Main Authors: | E. L. Nasonov, L. P. Ananyeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2025-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3757 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacotherapy of autoimmune rheumatic diseases – from monoclonal antibodies to CAR T cells: 20 years later
by: E. L. Nasonov, et al.
Published: (2024-06-01) -
Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation
by: L. P. Ananyeva, et al.
Published: (2019-07-01) -
ANTI-B-CELL THERAPY AT IMMUNE INFLAMMATORY RHEUMATIC DISEASES: EFFICACY AND TOLERABILITY IN 229 PATIENTS
by: L. P. Ananieva, et al.
Published: (2014-10-01) -
PROSPECTS FOR ANTI-B-CELL THERAPY IN RHEUMATOLOGY
by: E. L. Nasonov
Published: (2018-11-01) -
OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
by: E. P. Evdoshenko, et al.
Published: (2014-07-01)